← Back to Search

High sodium diet and low sodium diet for High Blood Pressure

N/A
Waitlist Available
Led By Robert M Carey, MD
Research Sponsored by University of Virginia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during the screening visit
Awards & highlights

Study Summary

Previous studies have demonstrated that single nucleotide polymorphisms (SNPs) of the sodium-bicarbonate co-transporter gene (SLC4A5) are associated with hypertension. We tested the hypothesis that SNPs in SLC4A5 are associated with salt sensitivity of blood pressure in 185 whites consuming an isocaloric constant diet with a randomized order of 7 days of low sodium (Na+) and 7 days of high Na+ intake. Salt sensitivity was defined as a ≥7-mm Hg increase in mean arterial pressure during a randomized transition between low and high Na+ diet. A total of 35 polymorphisms in 17 candidate genes were assayed, 25 of which were tested for association. Association analyses with salt sensitivity revealed 3 variants that associated with salt sensitivity. Of these, 2 SNPs in SLC4A5 (rs7571842 and rs10177833) demonstrated highly significant results and large effects sizes, using logistic regression. These 2 SNPs had P values of 1.0×10-4 and 3.1×10-4 with odds ratios of 0.221 and 0.221 in unadjusted regression models, respectively, with the G allele at both sites conferring protection. These SNPs remained significant after adjusting for body mass index and age (P=8.9×10-5 and 2.6×10-4 and odds ratios 0.210 and 0.286, respectively). Furthermore, the association of these SNPs with salt sensitivity was replicated in a second hypertensive population. Meta-analysis demonstrated significant associations of both SNPs with salt sensitivity (rs7571842 [P=1.2×10-5]; rs1017783 [P=1.1×10-4]). In conclusion, SLC4A5 variants are strongly associated with salt sensitivity of blood pressure in 2 separate white populations.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~study subjects will be observed 5 times during the 2 week intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and study subjects will be observed 5 times during the 2 week intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Blood pressure; Change in Mean Arterial Pressure from low salt diet to high salt diet
Secondary outcome measures
Genetic analysis for specified genes associated with hypertension
Urine sodium

Trial Design

1Treatment groups
Experimental Treatment
Group I: High sodium diet and low sodium dietExperimental Treatment1 Intervention
Each subject experiences both a high sodium and a low sodium diet.

Find a Location

Who is running the clinical trial?

University of VirginiaLead Sponsor
756 Previous Clinical Trials
1,244,906 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,844 Previous Clinical Trials
47,816,943 Total Patients Enrolled
Robert M Carey, MDPrincipal InvestigatorUniversity of Virginia
1 Previous Clinical Trials
44 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~20 spots leftby May 2025